North America Internal Neuromodulation Market by Type (Spinal Cord, Deep Brain, Sacral Nerve, Vagus Nerve, Gastric Neuro stimulator), Application (Parkinson's Disease, Chronic pain) – Analysis & Forecast to 2019
- Report Code: NE 1002
- Publish Date: May 2015
The North America neuromodulation market has been segmented by procedure, modality, and geography. On the basis of procedure, the market is further segmented into internal and external stimulation. The internal stimulation segment accounted for a share of 87.4% in the neuromodulation market. The market based on modality covers internal and external modality. The internal modality segment accounted for a share of 85.9% in the neuromodulation market.
The North American neuromodulation market shows a growth and is projected to grow at a CAGR of 10.5% by 2019. Technological advancements are driving the growth of this market. In addition, increasing neurological disorders such as Parkinson’s and epilepsy are fuelling the growth of this market.
The report also provided a detailed competitive landscaping of companies operating in this market. Segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals and product recalls of the major companies would be detailed. The major companies operating in this market are Medtronic Plc. (U.S.), St. Jude Medical (U.S.), Boston Scientific Corp. (U.S.), Cyberonics Inc. (U.S.), Biocontrol Medical (U.S.), and Greatbatch (U.S.).
Table of Contents
1 Introduction (Page No. - 9)
1.1 Objectives of the Study
1.2 Market Segmentation & Coverage
1.3 Stakeholders
2 Research Methodology (Page No. - 11)
2.1 Integrated Ecosystem of the Internal Neuromodulation Market
2.2 Arriving at the Internal Neuromodulation Market Size
2.2.1 Top-Down Approach
2.2.2 Bottom-Up Approach
2.2.3 Macroindicator-Based Approach
2.3 Assumptions
3 Executive Summary (Page No. - 17)
4 Market Overview (Page No. - 19)
4.1 Introduction
4.2 Internal Neuromodulation Market: Comparison With Neuromodulation (Parent) Market
4.3 Market Drivers and Inhibitors
5 North America Internal Neuromodulation Market, By Type (Page No. - 23)
5.1 Introduction
5.2 North America Spinal Cord Stimulation Market, By Country
5.3 North America Deep Brain Stimulation Market, By Country
5.4 North America Sacral Nerve Stimulation Market, By Country
5.5 North America Vagus Nerve Stimulation Market, By Country
5.6 North America Gastric Electrical Stimulation Market, By Country
6 North America Internal Neuromodulation Market, By Application (Page No. - 30)
6.1 Introduction
6.2 North America Internal Neuromodulation Market For Parkinson’s Disease, By Country
6.3 North America Internal Neuromodulation Market For Tremor, By Country
6.4 North America Internal Neuromodulation Market For Depression, By Country
6.5 North America Internal Neuromodulation Market For Other Applications, By Country
7 North America Internal Neuromodulation Market, By Geography (Page No. - 37)
7.1 Introduction
7.2 U.S. Internal Neuromodulation Market
7.2.1 U.S. Internal Neuromodulation Market, By Application
7.2.2 U.S. Internal Neuromodulation Market, By Type
7.3 Canada Internal Neuromodulation Market
7.3.1 Canada Internal Neuromodulation Market, By Application
7.3.2 Canada: Internal Neuromodulation Market, By Type
7.4 Mexico Internal Neuromodulation Market
7.4.1 Mexico Internal Neuromodulation Market, By Application
7.4.2 Mexico Internal Neuromodulation Market, By Type
8 Competitive Landscape (Page No. - 52)
8.1 Internal Neuromodulation Market, By Company
8.2 Company Presence in Internal Neuromodulation Market, By Type
8.3 New Product Launches
8.4 Regulatory Approvals
9 Company Profiles (Page No. - 55)
(Overview, Financials, Products & Services, Strategy, and Developments)*
9.1 Boston Scientific Corporation
9.2 Cerbomed GMBH
9.3 Cyberonics, Inc.
9.4 Depuy Synthes Companies
9.5 Enteromedics, Inc. (U.S.)
9.6 Medtronic, Inc. (U.S.)
9.7 St. Jude Medical
9.8 Synapse Biomedical, Inc.
9.9 Uroplasty, Inc. (U.S.)
*Details On Overview, Financials, Product & Services, Strategy, and Developments Might Not Be Captured in Case of Unlisted Company
10 Appendix (Page No. - 75)
10.1 Customization Options
10.1.1 Product Analysis
10.1.2 Epidemiology Data
10.1.3 Surgeons/Physicians Perception Analysis
10.1.4 Regulatory Framework
10.2 Related Reports
10.3 Introducing RT: Real-Time Market Intelligence
10.3.1 Snapshots
List of Tables (37 Tables)
Table 1 Global Internal Neuromodulation Peer Market Size, 2014 (USD MN)
Table 2 North American Internal Neuromodulation Market: Macroindicators, By Country, 2013 (USD MN)
Table 3 North America: Internal Neuromodulation Market: Comparison With Neuromodulation (Parent) Market, 2013 – 2019 (USD MN)
Table 4 North America: Internal Neuromodulation Market, By Type, 2013 - 2019 (USD MN)
Table 5 North America Internal Neuromodulation Market: Drivers and Inhibitors
Table 6 North America: Internal Neuromodulation Market, By Type, 2013 - 2019 (USD MN)
Table 7 North America: Spinal Cord Stimulation Market, By Country, 2013–2019 (USD MN)
Table 8 North America: Deep Brain Stimulation Market, By Country, 2013–2019 (USD MN)
Table 9 North America: Sacral Nerve Stimulation Market, By Country, 2013 - 2019 (USD MN)
Table 10 North America: Vagus Nerve Stimulation Market, By Country, 2013 - 2019 (USD MN)
Table 11 North America: Gastric Electrical Market, By Country, 2013 - 2019 (USD MN)
Table 12 North America: Internal Neuromodulation Market, By Application, 2013 - 2019 (USD MN)
Table 13 North America: Internal Neuromodulation Market For Parkinson’s Disease, By Country, 2013 - 2019 (USD MN)
Table 14 North America: Internal Neuromodulation Market For Tremor, By Country, 2013 - 2019 (USD MN)
Table 15 North America: Internal Neuromodulation Market For Depression, By Country, 2013 - 2019 (USD MN)
Table 16 North America: Internal Neuromodulation Market For Other Applications, By Country, 2013 - 2019 (USD MN)
Table 17 North America: Internal Neuromodulation Market, By Country, 2013 - 2019 (USD MN)
Table 18 U.S.: Internal Neuromodulation Market, By Application, 2013-2019 (USD MN)
Table 19 U.S.: Internal Neuromodulation Market, By Type, 2013 - 2019 (USD MN)
Table 20 Canada: Internal Neuromodulation Market, By Application, 2013-2019 (USD MN)
Table 21 Canada: Internal Neuromodulation Market, By Type, 2013 - 2019 (USD MN)
Table 22 Mexico: Internal Neuromodulation Market, By Application, 2013-2019 (USD MN)
Table 23 Mexico: Internal Neuromodulation Market, By Type, 2013 - 2019 (USD MN)
Table 24 Internal Neuromodulation Market: By Company
Table 25 Internal Neuromodulation Market: Company Share Analysis, 2013(%)
Table 26 North America Internal Neuromodulation Market: New Product Launches
Table 27 North America Internal Neuromodulation Market: Regulatory Approvals
Table 28 Boston Scientific Corporation: Key Financials, By Segment, 2009 - 2013 (USD MN)
Table 29 Boston Scientific Corporation: Key Financials, By Region, 2009 - 2012 (USD MN)
Table 30 Cyberonics, Inc.: Key Financials, 2009 - 2013 (USD MN)
Table 31 Johnson & Johnson, Inc. : Key Financials, By Segment, 2009 - 2013 (USD MN)
Table 32 Johnson & Johnson, Inc.: Key Financials, 2009 - 2013 (USD MN)
Table 33 Medtronic, Inc.: Key Financials, By Segment, 2009 - 2013 (USD MN)
Table 34 Medtronic, Inc.: Key Financials, 2009 - 2013 (USD MN)
Table 35 St. Jude Medical: Key Financials, By Segment, 2011 - 2013 (USD MN)
Table 36 St. Jude Medical: Key Financials, By Geography, 2009 - 2013 (USD MN)
Table 37 Uroplasty, Inc.: Key Financials, By Country, 2010 - 2013 (USD MN)
List of Figures (41 Figures)
Figure 1 North American Internal Neuromodulation Market: Segmentation & Coverage
Figure 2 Internal Neuromodulation Market: Integrated Ecosystem
Figure 3 Research Methodology
Figure 4 Top-Down Approach
Figure 5 Bottom-Up Approach
Figure 6 Macroindicator-Based Approach
Figure 7 North American Internal Neuromodulation Market Snapshot
Figure 8 Internal Neuromodulation Market: Comparison With Neuromodulation (Parent) Market
Figure 9 North America Internal Neuromodulation Market, By Type, 2013 (USD MN)
Figure 10 North America Internal Neuromodulation Market, By Type, 2014 vs 2019 (USD MN)
Figure 11 North America Spinal Cord Stimulation Market, By Country, 2013–2019 (USD MN)
Figure 12 North America Deep Brain Stimulation Market, By Country, 2013–2019 (USD MN)
Figure 13 North America: Sacral Nerve Stimulation Market, By Country, 2013 - 2019 (USD MN)
Figure 14 North America Vagus Nerve Stimulation Market, By Country, 2013 – 2019 (USD MN)
Figure 15 North America Gastric Electrical Market, By Country, 2013 - 2019 (USD MN)
Figure 16 North America: Internal Neuromodulation Market, By Application, 2013 - 2019 (USD MN)
Figure 17 North America: Internal Neuromodulation Market For Parkinson’s Disease, By Country, 2013 - 2019 (USD MN)
Figure 18 North America: Internal Neuromodulation Market For Tremor, By Country, 2013 - 2019 (USD MN)
Figure 19 North America: Internal Neuromodulation Market For Depression, By Country, 2013 - 2019 (USD MN)
Figure 20 North America: Internal Neuromodulation Market For Other Applications, By Country, 2013 - 2019 (USD MN)
Figure 21 North America: Internal Neuromodulation Market: Growth Analysis, By Geography, 2013-2019 (USD MN)
Figure 22 U.S. Internal Neuromodulation Market Overview, 2014 & 2019 (%)
Figure 23 U.S. Internal Neuromodulation Market, By Application, 2013-2019 (USD MN)
Figure 24 U.S. Internal Neuromodulation Market: Application Snapshot, 2014 vs 2019
Figure 25 U.S. Internal Neuromodulation Market, By Type, 2013 - 2019 (USD MN)
Figure 26 U.S. Internal Neuromodulation Market Share, By Type, 2014 vs 2019 (%)
Figure 27 Canada Internal Neuromodulation Market Overview, 2014 & 2019 (%)
Figure 28 Canada Internal Neuromodulation Market, By Application, 2013-2019 (USD MN)
Figure 29 Canada Internal Neuromodulation Market: Application Snapshot, 2014 vs 2019
Figure 30 Canada Internal Neuromodulation Market, By Type, 2013 - 2019 (USD MN)
Figure 31 Canada Internal Neuromodulation Market Share, By Type, 2014 vs 2019 (%)
Figure 32 Mexico Internal Neuromodulation Market Overview, 2014 & 2019 (%)
Figure 33 Mexico Internal Neuromodulation Market, By Application, 2013 - 2019 (USD MN)
Figure 34 Mexico Internal Neuromodulation Market: Application Snapshot, 2014 vs 2019
Figure 35 Mexico Internal Neuromodulation Market, By Type, 2013- 2019 (USD MN)
Figure 36 Mexico Internal Neuromodulation Market Share, By Type, 2014 vs 2019 (%)
Figure 37 Internal Neuromodulation: Company Product Coverage, By Type, 2013
Figure 38 Boston Scientific Corporation: Business Revenue Mix, 2013
Figure 39 Johnson & Johnson, Inc.: Revenue Mix, 2013
Figure 40 Medtronic, Inc.: Revenue Mix, 2013
Figure 41 St. Jude Medical: Revenue Mix, 2013
Neuromodulation has emerged as one of the fastest-growing segments in the medical devices market. This is due to the high demand for minimally invasive and non–invasive treatment. With the increasing technological advancements, neuromodulation is expected to witness high growth during the forecast period. It provides symptomatic relief from chronic pain, incontinence, depression, heart failure, headache, epilepsy, and others.
There has been a rapid growth in the neuromodulation market, worldwide. This is due to the rising number of chronic neurological disorders, such as epilepsy, Parkinson’s, and Alzheimer’s. The other factors driving this market are technological advancements and favoring reimbursement policies.
The North America neuromodulation market has been segmented by procedure, modality, and geography. On the basis of procedure, the market is further segmented into internal and external stimulation. The internal stimulation segment accounted for a higher market share in the neuromodulation market. The market based on modality covers internal and external modality. The internal modality segment accounted for a higher market share in the neuromodulation market.
Further, the market is segmented in terms of geography. Countries, such as the U.S., Canada, and Mexico are included in this market report. The market in the U.S. accounted for the highest share.
Medtronic Plc. (U.S.), St. Jude Medical (U.S.), Boston Scientific Corp. (U.S.), Cyberonics Inc. (U.S.), Biocontrol Medical (U.S.), and Greatbatch (U.S.) are some of the major players operating in this market.
The report gives comprehensive and detailed insights about the segments in particular countries in the geographic analysis chapter. It presents in-depth competitive landscape covering major developments in the region for last four years (2012 to 2015), and also the region specific company share analysis for the year of 2013.
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American Nerve Repair & Regeneration Market The North American Nerve Repair and Regeneration market was pegged at $2841.03 million in 2013 and expected to be $4709.59 million by 2018, growing at a CAGR of 10.6%. Nerve Repair and Regeneration market segment includes direct nerve repair, nerve grafting, and stem cell therapy, while the neuromodulation segment includes internal stimulation devices such as Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), and external stimulation devices such as Transcranial Magnetic Stimulation (TMS) and Transcutaneous Electrical Nerve Stimulation (TENS). The main companies operating The North American Nerve Repair and Regeneration market segment include Integra LifeSciences Corporation (U.S.), Stryker Corporation (U.S.), AxoGen, Inc. (U.S.), and Polyganics (The Netherlands). The key players in the neuromodulation segment include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.). |
Apr 2015 |
|
|
European Nerve Repair & Regeneration Market The nerve repair and regeneration market in Europe has displayed significant growth at a CAGR of 11.9%. Germany garnered the maximum market share and is expected to grow at a CAGR of 11.1%, followed by France and the U.K. |
Apr 2015 |
|
|
Asian Nerve Repair & Regeneration Market The Asian Nerve Repair and Regeneration market was pegged at $4680.82 million in 2013 and expected to be $8112.19 million by 2018, growing at a CAGR of 11.6%. market segment includes direct nerve repair, nerve grafting, and stem cell therapy, while the neuromodulation segment includes internal stimulation devices such as Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), and external stimulation devices such as Transcranial Magnetic Stimulation (TMS) and Transcutaneous Electrical Nerve Stimulation (TENS). The main companies operating in peripheral nerve repair segment include Integra LifeSciences Corporation (U.S.), Stryker Corporation (U.S.), AxoGen, Inc. (U.S.), and Polyganics (The Netherlands). The key players in the neuromodulation segment include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.). |
Mar 2015 |
